Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunotherapy of cancer patients using CAR T or CAR NK cells combined with hematopoietic cells that have a modified or deleted target antigen

Immunotherapy of cancer patients using CAR T or CAR NK cells combined with hematopoietic cells that have a modified or deleted target antigen

US Patent 12246065 · Granted Mar 11, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for manufacturing a patient specific cell population using a multifunctio2025
Compositions and methods for treating cancer with DuoCARs2025
Adapter-based retroviral vector system for the selective transduction of target 2025
Reducing side effects of immunotherapy using genetically modified hematopoietic 2025
Reducing side effects of immunotherapy using genetically modified hematopoietic 2025
Reducing side effects of immunotherapy using genetically modified hematopoietic 2025
Reducing side effects of immunotherapy using genetically modified hematopoietic 2025
Reducing side effects of immunotherapy using genetically modified hematopoietic 2025
Sterile connector2025
Regulatory T cell expressing a chimeric antigen receptor2024
Reagents for detection of chimeric antigen receptor cells2024
CD62L specific lentiviral vector particle for targeted transduction of T cell su2024